Social Responsibility
First Health Pharmaceuticals took its Social Responsibility very seriously when it donated the largest part of its antivirus pipeline to First Health United. The decision is testimony to the fact that profit maximization is clearly not the only goal of the company and that Social Responsibility is a driving force within the First Health group.
The antiviral research is a core of our operations:
The antiviral research is a core of our operations. The Dengue antivirus compound that First Health United wants to develop will target the Severe Dengue patient population of the developing countries (where Dengue is endemic).
Given the scientific research potential of First Health Pharmaceuticals based on the DDX3 helicase inhibiting antiviral agents and its prestigious academic partners, First Health United wants to make a real difference in the world by developing an effective Severe Dengue antivirus agent based on FHP’s patented IP, with the intention to make this antivirus available at cost price – or whenever possible for free – to developing countries worldwide.
Given the scientific research potential of First Health Pharmaceuticals based on the DDX3 helicase inhibiting antiviral agents and its prestigious academic partners, First Health United wants to make a real difference in the world by developing an effective Severe Dengue antivirus agent based on FHP’s patented IP, with the intention to make this antivirus available at cost price – or whenever possible for free – to developing countries worldwide.
- PhilanthropyProjects benefiting the developing countries
Philanthropic support of projects benefiting the developing countries, which involves donating First Health Pharmaceuticals’ stakeholders’ expertise and time to our worthy cause, the Dengue project.
- Social
- Ethical labor